48.95
0.90 (1.87%)
| Previous Close | 48.05 |
| Open | 48.85 |
| Volume | 124,000 |
| Avg. Volume (3M) | 244,402 |
| Market Cap | 28,641,329,152 |
| Price / Earnings (TTM) | 21.01 |
| Price / Sales | 2.93 |
| Price / Book | 1.02 |
| 52 Weeks Range | |
| Earnings Date | 26 Mar 2025 - 31 Mar 2025 |
| TTM Dividend Yield | 3.60% |
| Profit Margin | 13.80% |
| Operating Margin (TTM) | 17.76% |
| Diluted EPS (TTM) | 2.33 |
| Quarterly Revenue Growth (YOY) | -19.10% |
| Quarterly Earnings Growth (YOY) | -59.70% |
| Total Debt/Equity (MRQ) | 0.70% |
| Current Ratio (MRQ) | 6.69 |
| Operating Cash Flow (TTM) | 1.74 B |
| Levered Free Cash Flow (TTM) | -193.76 M |
| Return on Assets (TTM) | 1.92% |
| Return on Equity (TTM) | 4.40% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (HK) | Mixed | Mixed |
| Biotechnology (Global) | Mixed | Mixed | |
| Stock | ASYMCHEM | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -2.0 |
| Average | -0.38 |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| ASYMCHEM | 29 B | 3.60% | 21.01 | 1.02 |
| JUNSHI BIO | 24 B | - | - | 1.56 |
| ZAI LAB | 23 B | - | - | 4.38 |
| REMEGEN | 14 B | - | - | 2.74 |
| AKESO | 55 B | - | - | 9.50 |
| INNOVENT BIO | 53 B | - | - | 4.54 |
|
Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development manufacturing organization solutions throughout the drug development and manufacturing process. The Group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing which focuses on innovation and commercial application of pharmaceutical technology. It has geographic areas in the Chinese Mainland and Overseas. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Mid Core |
| % Held by Institutions | 41.34% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |